FDA pulls Zantac, other heartburn meds off the market

April 2, 2020

CNN

The U.S. Food and Drug Administration has ordered all manufacturers and retailers to pull all prescription and over-the-counter ranitidine drugs, known by the brand name Zantac, from the market immediately after discovering a contaminant in the heartburn medication. The contaminant, N-nitrosodimethylamine or NDMA, is a probable carcinogen in humans.

 

Recent News